中医治疗肺炎支原体肺炎的研究进展

Research Advances in Traditional Chinese Medicine Treatment for Mycoplasma Pneumoniae Pneumonia

摘要: 肺炎支原体肺炎属中医“肺炎喘嗽”范畴，近年来其发病率增高且呈低龄化趋势。中医药治疗本病历史悠久，治疗方法较多，具有疗效稳定、安全性高等显著优势。目前认为其病因包括外感邪气等，病位在肺，常累及多脏，病理因素多样。近年来的研究显示，中医药内治及外治方法疗效肯定，辨证论治经验较为丰富，然而中医药治疗本病的作用机制复杂未明。未来需要增加相关基础研究，探究中药复方的各组分药理机制，或深层次治疗机制，以期为临床应用提供依据。

Abstract: Mycoplasma pneumoniae pneumonia falls within the scope of “pneumonia with wheezing and coughing” in traditional Chinese medicine (TCM). In recent years, its incidence has risen, with a trend towards affecting younger age groups. Traditional Chinese medicine has a long history of treating this condition, employing numerous therapeutic approaches that offer distinct advantages including stable efficacy and high safety. Current understanding suggests its pathogenesis involves factors such as exogenous pathogenic factors, with the primary site of disease being the lungs, frequently involving multiple organs, and presenting diverse pathological factors. Recent studies demonstrate the confirmed efficacy of both internal and external TCM therapies, with substantial experience in pattern differentiation and treatment. However, the complex mechanisms underlying TCM’s therapeutic effects remain poorly understood. Future research should focus on expanding foundational studies to elucidate the pharmacological mechanisms of individual components within TCM formulas, or to explore deeper therapeutic pathways, thereby providing evidence to inform clinical practice.